Related Experiment Video

Updated: Sep 3, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

341

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities

Jing Li1, Hongli Duan1, Yan Liu1

  • 1School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.

Pharmaceutics
|July 27, 2022
PubMed

Insights

Obesity treatments face challenges with current drugs. Emerging strategies, particularly biomaterials for targeted delivery, offer promising new avenues for combating obesity and its associated health issues.

Area of Science:

  • Biomaterials Science
  • Pharmacology
  • Public Health

Background:

  • Obesity is a significant global health problem, leading to serious comorbidities like type 2 diabetes and cardiovascular disease.
  • Current pharmacotherapies for obesity have limitations including poor bioavailability, specificity, and toxicity.
  • Approved anti-obesity medications are few, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

  • To review emerging obesity treatment strategies, focusing on the role of biomaterials.
  • To analyze the functions and applications of biomaterials in targeted obesity treatment.
  • To discuss future prospects and challenges in biomaterial-based obesity therapies.

Main Methods:

  • Systematic review and analysis of current obesity treatment strategies.
  • Evaluation of small-molecule drugs, natural products, and biotechnological drugs.
  • In-depth examination of biomaterial applications in obesity management.

Main Results:

  • Biomaterials show advanced functions for targeted delivery in obesity treatment.
  • Biomaterials exhibit significant biological activities and therapeutic potential.
  • Emerging strategies integrate materials science, chemistry, and biotechnology for obesity care.

Conclusions:

  • Biomaterial-based strategies represent a promising frontier in obesity treatment.
  • Further research is needed to overcome challenges in biomaterial development and application.
  • Multidisciplinary integration is key to advancing novel obesity therapeutics.
Keywords:
biomaterialdrug deliveryobesity

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

586
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.1K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
344
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
607
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
164
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
124
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K